Study: PrEP as safe as aspirin

Darren Wee | Gay Star News | January 12, 2016

A new study has found that Truvada used as pre-Exposure prophylaxis (PrEP) is as safe as aspirin in the short to medium term.

Researchers at the University of California, Los Angeles compared five major studies on PrEP and two major studies on aspirin safety.

Their conclusion?

‘PrEP for HIV infection favorably compares to aspirin in terms of user safety. While long-term studies are needed, providers should feel reassured about the safety of short- and medium-term PrEP for HIV infection with FTC-TDF [Emtricitabine-Tenofovir Disoproxil Fumarate].’

Read more


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s